Funding news
INFEX Therapeutics logo

INFEX Therapeutics Secures $9.0M Funding

Recently funded · $9.0M UnknownHospitals and Health CareGBView source

Get the full INFEX Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

INFEX Therapeutics, the Alderley Park-based biotech firm focused on innovative drugs for infectious diseases, has secured $9.0M in new investment. The company, which initially built its reputation on acquiring, developing, and licensing therapies for pandemic infections, is now significantly expanding its scope.

This fresh capital will fuel INFEX's push to develop a broader portfolio of new treatments for critical priority infectious diseases. Its mission remains to address unmet patient needs by bringing novel drugs into clinical trials to combat life-threatening infections.

Other United Kingdom companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Turnkey logo

Turnkey

United States

$12.5M
2
Kelso Group Holdings Plc logo

Kelso Group Holdings Plc

United Kingdom

$819.0K
3
Rendesco logo

Rendesco

United Kingdom

$126.0M
4
VIOLETTE_FR logo

VIOLETTE_FR

United States

$5.0M
5
Fresh People Limited logo

Fresh People Limited

United Kingdom

$3.1M